Weight-loss drug Wegovy can be marketed for heart benefits after FDA label update – CNN

1. Weight-loss drug Wegovy can be marketed for heart benefits after FDA label update  CNN
2. Novo Nordisk’s Wegovy wins FDA approval for cutting heart disease risks, in move that could expand insurance coverage  CNBC
3. FDA approves Wegovy to reduce heart attack and stroke risk  NBC News
4. Weight loss drug Wegovy approved for heart health  The Hill
5. Novo’s obesity superstar Wegovy wins FDA nod to cut cardio risks in key label expansion  FiercePharma

Source: Weight-loss drug Wegovy can be marketed for heart benefits after FDA label update – CNN